Differences between Metastasizing and Invasive Bladder Cancer
Bladder cancer is one of the most serious diseases a person can develop. It is one of the most commonly occurring forms of cancer in the United States and has an extremely high recurrence rate. Additionally, one of bladder cancer’s other major dangers is that it is likely to metastasize and invade other regions of the body, decreasing a person’s chances of survival and costing exorbitant amounts of money in medical fees.
If you have taken Actos to help control your diabetes and have been diagnosed with bladder cancer, the two seemingly unrelated occurrences may actually be closely tied to one another. The Type-2 diabetes drug Actos has been shown to greatly increase a person’s risk of developing bladder cancer. Contact an experienced Actos lawsuit lawyer of Williams Kherkher at 800-641-9810 to discuss your options for holding the pharmaceutical company accountable for its negligence.
Metastasis vs. Invasion
Cancer spreads through a person’s body in two primary ways, invasion and metastasis. When a cancer spreads to areas adjacent to its origination point, it is called invasive. It does this commonly by invading the muscles around the bladder as it grows, causing patients to slowly lose control of their bladder’s activity.
When bladder cancer metastasizes, it spreads to a region far away from the bladder through the blood stream and lymph nodes. Metastasis is especially dangerous, as those who have developed bladder cancer in other regions of their body have exponentially lower chances of survival than those whose cancer is found only in the bladder.
If you have been diagnosed with bladder cancer as a result of your Actos use, the Actos lawsuit attorneys of Williams Kherkher may be able to help you pursue an Actos lawsuit against the responsible drug manufacturer and seek compensation for your medical costs and other Actos injury related expenses. Call our experienced Actos lawyers at 800-641-9810 for a free case evaluation.